Insider trading

Period: 120 months Stock: MC + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

234 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

234 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

234 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

234 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
234 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
234 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

234 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
23 Feb 2018
LEAMAN J RICHARD III MD & Vice Chairman
Sold, plan not stated
$51.35K 1,000 at 51.35
6.4%
22 Feb 2018
MOELIS KENNETH Chairman and CEO
Sold, plan not stated
$2.46M 49,116 at 50.00
50.0%
Sold half or more
22 Feb 2018
MAHMOODZADEGAN NAVID MD & Co-President
Sold, plan not stated
$2.17M 43,470 at 50.00
50.0%
Sold half or more
22 Feb 2018
RAICH JEFFREY MD & Co-President
Sold, plan not stated
$2.17M 43,470 at 50.00
50.0%
Sold half or more
22 Feb 2018
LEAMAN J RICHARD III MD & Vice Chairman
Sold, plan not stated
$778.60K 15,572 at 50.00
50.0%
Sold half or more
22 Feb 2018
CRAIN ELIZABETH Chief Operating Officer
Sold, plan not stated
$429.15K 8,583 at 50.00
50.0%
Sold half or more
22 Feb 2018
WATANABE OSAMU R. General Counsel and Secretary
Sold, plan not stated
$259.25K 5,185 at 50.00
49.4%
22 Feb 2018
SIMON JOSEPH Chief Financial Officer
Sold, plan not stated
$126.40K 2,528 at 50.00
24.8%
2 Nov 2017
MOELIS KENNETH Chairman and CEO · indirect
Sold, plan not stated
$368.78K 8,656 at 42.60
43.6%
1 Nov 2017
MOELIS KENNETH Chairman and CEO · indirect
Sold, plan not stated
$939.45K 22,000 at 42.70
52.6%
Sold half or more
31 Oct 2017
MOELIS KENNETH Chairman and CEO · indirect
Sold, plan not stated
$599.08K 14,000 at 42.79
25.1%
30 Oct 2017
MOELIS KENNETH Chairman and CEO · indirect
Sold, plan not stated
$738.52K 17,300 at 42.69
23.6%
27 Oct 2017
MOELIS KENNETH Chairman and CEO · indirect
Sold, plan not stated
$402.92K 9,500 at 42.41
11.5%
16 May 2017
MOELIS KENNETH Chairman and CEO · indirect
Sold, plan not stated
$305.83K 8,200 at 37.30
8.5%
15 May 2017
MOELIS KENNETH Chairman and CEO · indirect
Sold, plan not stated
$256.06K 6,800 at 37.66
6.6%
9 May 2017
SIMON JOSEPH Chief Financial Officer
Sold, plan not stated
$48.50K 1,263 at 38.40
100%
Sold half or more
27 Apr 2017
RAICH JEFFREY MD & Co-President
Sold, plan not stated
$268.58K 6,967 at 38.55
100%
Sold half or more
27 Apr 2017
Callesano Christopher SVP & Principal Acct Officer
Sold, plan not stated 2×
$136.44K 3,533 at 38.62
100%
Sold half or more
26 Apr 2017
MOELIS KENNETH Chairman and CEO
Sold, plan not stated
$1.24M 32,504 at 38.12
23.6%
26 Apr 2017
RAICH JEFFREY MD & Co-President
Sold, plan not stated
$929.29K 24,378 at 38.12
100%
Sold half or more
26 Apr 2017
MAHMOODZADEGAN NAVID MD & Co-President
Sold, plan not stated
$929.29K 24,378 at 38.12
100%
Sold half or more
26 Apr 2017
LEAMAN J RICHARD III MD & Vice Chairman
Sold, plan not stated
$557.54K 14,626 at 38.12
100%
Sold half or more
26 Apr 2017
CRAIN ELIZABETH Chief Operating Officer
Sold, plan not stated
$315.94K 8,288 at 38.12
100%
Sold half or more
26 Apr 2017
SIMON JOSEPH Chief Financial Officer
Sold, plan not stated
$182.06K 4,776 at 38.12
100%
Sold half or more
26 Apr 2017
WATANABE OSAMU R. General Counsel and Secretary
Sold, plan not stated
$161.06K 4,225 at 38.12
97.0%
Sold half or more
26 Apr 2017
Callesano Christopher SVP & Principal Acct Officer
Sold, plan not stated
$52.68K 1,382 at 38.12
100%
Sold half or more
22 Feb 2017
MOELIS KENNETH Chairman and CEO
Sold, plan not stated
$1.33M 35,982 at 36.99
25.5%
22 Feb 2017
MAHMOODZADEGAN NAVID MD & Co-President
Sold, plan not stated
$827.76K 22,378 at 36.99
100%
Sold half or more
22 Feb 2017
RAICH JEFFREY MD & Co-President
Sold, plan not stated
$827.76K 22,378 at 36.99
100%
Sold half or more
22 Feb 2017
LEAMAN J RICHARD III MD & Vice Chairman
Sold, plan not stated
$373.30K 10,092 at 36.99
100%
Sold half or more
22 Feb 2017
CRAIN ELIZABETH Chief Operating Officer
Sold, plan not stated
$197.97K 5,352 at 36.99
100%
Sold half or more
22 Feb 2017
WATANABE OSAMU R. General Counsel and Secretary
Sold, plan not stated
$128.21K 3,466 at 36.99
96.4%
Sold half or more
22 Feb 2017
SIMON JOSEPH Chief Financial Officer
Sold, plan not stated
$114.56K 3,097 at 36.99
100%
Sold half or more
22 Feb 2017
Callesano Christopher SVP & Principal Acct Officer
Sold, plan not stated
$56.67K 1,532 at 36.99
100%
Sold half or more
Showing 201–234 of 234. ← Newer Page 5 of 5